Literature DB >> 3989122

Acute effects of amiodarone on the electrophysiologic properties of isolated neonatal and adult cardiac fibers.

S M Yabek, R Kato, B N Singh.   

Abstract

The acute cellular electrophysiologic actions of amiodarone on isolated neonatal and adult canine ventricular muscle and Purkinje fibers were evaluated using standard microelectrode techniques. Amiodarone, 10(-6) to 5 X 10(-5) M (0.68 to 34 micrograms/ml), significantly (p less than 0.05) prolonged adult ventricular muscle action potential duration and voltage-dependent refractoriness at all concentrations, thereby demonstrating typical class III antiarrhythmic effects. Similar concentrations had no significant effects on neonatal ventricular muscle. Amiodarone significantly shortened action potential duration and refractoriness of both neonatal and adult Purkinje fibers, with neonatal fibers having a greater sensitivity to the drug. At the standard stimulation rate of 1 Hz, amiodarone had no effects on action potential amplitude or maximal rate of rise of phase 0 of the action potential (Vmax) of any tissues. At faster stimulation frequencies (2 to 4 Hz), amiodarone produced frequency-dependent decreases in action potential amplitude and Vmax of all neonatal and adult preparations. The data indicate that amiodarone exhibits a complex aggregate of electrophysiologic actions that include significant frequency-related class I effects. Compared with adult myocardium, neonatal tissues demonstrated altered responsiveness to amiodarone, a feature common to many antiarrhythmic compounds.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989122     DOI: 10.1016/s0735-1097(85)80012-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes.

Authors:  H Honjo; I Kodama; K Kamiya; J Toyama
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 3.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 4.  Recent advances in understanding the pharmacology of amiodarone.

Authors:  S Nattel; M Talajic
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 5.  Amiodarone in long term prophylaxis.

Authors:  D Katritsis; A J Camm
Journal:  Drugs       Date:  1991       Impact factor: 9.546

6.  Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations.

Authors:  Serge Sicouri; Luiz Belardinelli; Leif Carlsson; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2009-02-27

7.  Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants.

Authors:  Silvia Burri; Maja Isabel Hug; Urs Bauersfeld
Journal:  Eur J Pediatr       Date:  2003-09-24       Impact factor: 3.183

Review 8.  New antiarrhythmic drugs in pediatric use: amiodarone.

Authors:  T Paul; P Guccione
Journal:  Pediatr Cardiol       Date:  1994 May-Jun       Impact factor: 1.655

9.  Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle.

Authors:  I Kodama; R Suzuki; K Kamiya; H Iwata; J Toyama
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

10.  Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.

Authors:  Y Nakaya; V Elharrar; B Surawicz
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.